Metabolic glycoengineered exosomes enable in situ PD-L1-Fc assembly for targeted immunotherapy in ulcerative colitis.

Shen H, Li S, Jiang S, Wu Q, Xu J, Fan W, Wang X, Yue Y, Xu W

Open source

DOI
10.1186/s12951-026-04909-x
Published
2026 Aug 12
Container
Journal of nanobiotechnology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12951-026-04909-x,
  title = {Metabolic glycoengineered exosomes enable in situ PD-L1-Fc assembly for targeted immunotherapy in ulcerative colitis.},
  author = {Shen H and Li S and Jiang S and Wu Q and Xu J and Fan W and Wang X and Yue Y and Xu W},
  year = {2026},
  journal = {Journal of nanobiotechnology},
  doi = {10.1186/s12951-026-04909-x},
  url = {https://doi.org/10.1186/s12951-026-04909-x}
}

RIS

TY  - JOUR
TI  - Metabolic glycoengineered exosomes enable in situ PD-L1-Fc assembly for targeted immunotherapy in ulcerative colitis.
AU  - Shen H
AU  - Li S
AU  - Jiang S
AU  - Wu Q
AU  - Xu J
AU  - Fan W
AU  - Wang X
AU  - Yue Y
AU  - Xu W
PY  - 2026
JO  - Journal of nanobiotechnology
DO  - 10.1186/s12951-026-04909-x
UR  - https://doi.org/10.1186/s12951-026-04909-x
ER  - 

APA

H, S., S, L., S, J., Q, W., J, X., W, F., X, W., Y, Y., & W, X. (2026). Metabolic glycoengineered exosomes enable in situ PD-L1-Fc assembly for targeted immunotherapy in ulcerative colitis.. Journal of nanobiotechnology. https://doi.org/10.1186/s12951-026-04909-x

Source records